Radiomics Predicts Lenvatinib Success in Liver Cancer
In the realm of oncology, the quest for precision medicine has led to intriguing advancements that hold promise for cancer ...
Tag: multi-targeted tyrosine kinase inhibitors
RALOX-HAIC Plus Lenvatinib Boosts Elderly Liver Cancer Survival
A groundbreaking study published in BMC Cancer unveils a promising therapeutic advancement for elderly patients suffering from unresectable hepatocellular carcinoma ...
Rechallenging Immunotherapy Plus Anlotinib in Lung Cancer
In the relentless battle against advanced non-small cell lung cancer (NSCLC), a groundbreaking retrospective study has shed light on the ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!